Health Care Company United Therapeutics Announces Acquisition of Miromatrix Medical
Portfolio Pulse from Benzinga Insights
United Therapeutics (NASDAQ:UTHR) has announced the acquisition of Miromatrix Medical (NASDAQ:MIRO) for $91 million in cash, expected to be completed in Q4 of 2023. United Therapeutics specializes in drug development for pulmonary arterial hypertension, while Miromatrix Medical is a life sciences company pioneering bioengineering fully transplantable organs.
October 30, 2023 | 3:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Miromatrix Medical is being acquired by United Therapeutics for $91 million in cash.
The acquisition by United Therapeutics could provide Miromatrix Medical with the necessary resources to further develop and commercialize its products. This could potentially lead to increased revenues and profitability in the future.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
United Therapeutics is acquiring Miromatrix Medical, which could potentially expand its product portfolio.
The acquisition of Miromatrix Medical could potentially expand United Therapeutics' product portfolio and strengthen its position in the healthcare sector. This could potentially lead to increased revenues and profitability in the future.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100